Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin + Dexmedetomidine for Fibromyalgia
NCT07230197Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Average Pain Intensity at 4 weeks. Started Sep 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07230197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230197.